Search Products | My Account | Shopping Cart   
GeneCopoeia – ORF cDNA, shRNA, miRNA
   You are here: Home > Product > Lentiviral >

Lentifect™ Crude and Purified Lentiviral Particles — high titers and ready to transduce

Lentiviral vectors provide potent vehicles for delivery of genes into a wide range of cell types including difficult-to-transfect cells. Lentiviral particles transduce cells and integrate into the host genome in dividing and post-mitotic cells resulting in long-term expression of the transgene both in vivo and in vitro.

Producing, concentrating and titrating lentiviral particles, however, is time consuming and requires some experience to achieve high titers and consistent results.

When resources are limited, or accelerating your research is a top priority, GeneCopoeia provides efficient scientific expertise for reliable production of viral particles. Several popular varieties are already in stock.

Transduction of H1299 cells with GeneCopoeia eGFP lentiviral particles



    Panel A. Numbers correspond to the volume of crude eGFP particles used.



    Panel B. Numbers correspond to the volume of purified eGFP particles used.

Figure 1. H1299 cells (ATCC) in 24-well plates were transduced with the indicated amounts of eGFP either crude lentiviral particles, catalog number LP-EGFP-LV105 (Panel A) or purified particles, catalog number LPP-EGFP-LV105 (Panel B) in the presence of 5 µg/ml of polybrene. The expression of eGFP was checked with a fluorescence microscope 72d hours post-transduction.

GeneCopoeia produces crude and purified lentiviral particles for the following nucleic acids:

  • shRNA
  • miRNA
  • full-length ORF cDNA genes
  • iPS reprogramming genes

Fresh high-titer stocks ready to transduce

GeneCopoeia lentiviral particles are produced from standardized protocols using high-purity plasmid DNA preparations and EndoFectin™ Lenti transfection and TiterBoost™ reagents ensuring production of the highest-titers possible of crude viral supernatant and purified particles ever achieved. Ready-for-transduction, lentiviral preps from GeneCopoeia provide the following advantages:

  • A cost-effective choice for busy labs
  • A reliable lentiviral source for consistent quality from lot to lot
  • Efficient transduction of difficult-to-transfect cells or animal models

Ready-to-transduce lentiviral particles from GeneCopoeia provide an economical and time-saving solution for labs that wish to fast-track their research and/or lack the skill and materials required to produce lentiviral particles efficiently.

GeneCopoeia has several lentiviral particles ready-to-go. Custom orders take two to six weeks to fill.

Please inquire for custom-made particles and/or download general instructions

PDF Lentiviral Production Guidelines
Email:inquiry@genecopoeia.com
Call: 866-360-9531 or 301-762-0888

Lentifect™ Purified Lentiviral Particles(see table below for crude particles)

Buy
Catalog#
Product
Description*
LPP-CMYC-LV105-025 c-Myc Lentifect™ Purified Lentiviral Particles
(25 µl x 1 vial)
≈ 8 x 109 copies/ml lentiviral particles ready for transduction, 25 µl
LPP-EGFP-LV105-025 eGFP Lentifect™ Purified Lentiviral Particles
(25 µl x 1 vial)
≈ 1 x 1011 copies/ml control lentiviral particles ready for transduction, 25 µl
LPP-FLUC-LV105-025 Firefly Luciferase Lentifect™ Purified Lentiviral Particles
(25 µl x 1 vial)
≈ 1 x 109 copies/ml control lentiviral particles ready for transduction, 25 µl
LPP-KLF4-LV105-025 Klf4 Lentifect™ Purified Lentiviral Particles
(25 µl x 1 vial)
≈ 1 x 109 copies/ml lentiviral particles ready for transduction, 25 µl
LPP-MCHR-LV105-025 mCherry Lentifect™ Purified Lentiviral Particles
(25 µl x 1 vial)
≈ 1 x 1011 copies/ml control lentiviral particles ready for transduction, 25 µl
LPP-NEG-LV105-025 Negative Control Lentifect™ Purified Lentiviral Particles
(25 µl x 1 vial)
≈ 3.3 x 1011 copies/ml control lentiviral particles ready for transduction, 25 µl
LPP-OCT4-LV105-025 Oct4 Lentifect™ Purified Lentiviral Particles
(25 µl x 1 vial)
≈ 4.5 x 109 copies/ml lentiviral particles ready for transduction, 25 µl
LPP-RLUC-LV105-025 Renilla Luciferase Lentifect™ Purified Lentiviral Particles
(25 µl x 1 vial)
≈ 1 x 109 copies/ml control lentiviral particles ready for transduction, 25 µl
LPP-SOX2-LV105-025 Sox2 Lentifect™ Purified Lentiviral Particles
(25 µl x 1 vial)
≈ 3.4 x 107 copies/ml lentiviral particles ready for transduction, 25 µl

*Titer determined by quantitative PCR on purified lentiviral supernatant.


Transduction of H1299 cells with GeneCopoeia mCherry lentiviral particles

Figure 2. H1299 cells (ATCC) in 24-well plates were transduced with the indicated amounts of crude mCherry lentiviral particles, catalog number LP-MCHR-LV105 in the presence of 5 µg/ml of polybrene. The expression of eGFP was checked with a fluorescence microscope 72d hours post-transduction.

Lentifect™ Crude Lentiviral Particles (see table above for crude particles)

Buy
Catalog#
Product
Description*
LP-CMYC-LV105-0200 c-Myc Lentifect™ Lentiviral Particles
(200 µl x 1 vial)
≈ 8 x 108 TU/ml lentiviral particles ready for transduction, 200 µl
LP-CMYC-LV105-0205 c-Myc Lentifect™ Lentiviral Particles
(200 µl x 5 vials)
≈ 8 x 108 TU/ml lentiviral particles ready for transduction, 5 x 200 µl
LP-CMYC-LV105-1000 c-Myc Lentifect™ Lentiviral Particles
(1 ml x 1 vial)
≈ 8 x 108 TU/ml lentiviral particles ready for transduction, 1 x 1 ml
LP-EGFP-LV105-0200 eGFP Lentifect™ Lentiviral Particles
(200 µl x 1 vial)
≈ 1 x 1010 TU/ml control lentiviral particles ready for transduction, 200 µl
LP-EGFP-LV105-0205 eGFP Lentifect™ Lentiviral Particles
(200 µl x 5 vials)
≈ 1 x 1010 TU/ml control lentiviral particles ready for transduction, 5 x 200 µl
LP-EGFP-LV105-1000 eGFP Lentifect™ Lentiviral Particles
(1 ml x 1 vial)
≈ 1 x 1010 TU/ml control lentiviral particles ready for transduction, 1 x 1 ml
LP-FLUC-LV105-0200 Firefly Luciferase Lentifect™ Lentiviral Particles
(200 µl x 1 vial)
≈ 1 x 108 TU/ml control lentiviral particles ready for transduction, 200 µl
LP-FLUC-LV105-0205 Firefly Luciferase Lentifect™ Lentiviral Particles
(200 µl x 5 vials)
≈ 1 x 108 TU/ml control lentiviral particles ready for transduction, 5 x 200 µl
LP-FLUC-LV105-1000 Firefly Luciferase Lentifect™ Lentiviral Particles
(1 ml x 1 vial)
≈ 1 x 108 TU/ml control lentiviral particles ready for transduction, 1 x 1 ml
LP-KLF4-LV105-0200 Klf4 Lentifect™ Lentiviral Particles
(200 µl x 1 vial)
≈ 1 x 108 TU/ml lentiviral particles ready for transduction, 200 µl
LP-KLF4-LV105-0205 Klf4 Lentifect™ Lentiviral Particles
(200 µl x 5 vials)
≈ 1 x 108 TU/ml lentiviral particles ready for transduction, 5 x 200 µl
LP-KLF4-LV105-1000 Klf4 Lentifect™ Lentiviral Particles
(1 ml x 1 vial)
≈ 1 x 108 TU/ml lentiviral particles ready for transduction, 1 x 1 ml
LP-MCHR-LV105-0200 mCherry Lentifect™ Lentiviral Particles
(200 µl x 1 vial)
≈ 1 x 1010 TU/ml control lentiviral particles ready for transduction, 200 µl
LP-MCHR-LV105-0205 mCherry Lentifect™ Lentiviral Particles
(200 µl x 5 vials)
≈ 1 x 1010 TU/ml control lentiviral particles ready for transduction, 5 x 200 µl
LP-MCHR-LV105-1000 mCherry Lentifect™ Lentiviral Particles
(1 ml x 1 vial)
≈ 1 x 1010 TU/ml control lentiviral particles ready for transduction, 1 x 1 ml
LP-NEG-LV105-0200 Negative Control Lentifect™ Lentiviral Particles
(200 µl x 1 vial)
≈ 3.3 x 1010 copies/ml control lentiviral particles ready for transduction, 200 µl
LP-NEG-LV105-0205 Negative Control Lentifect™ Lentiviral Particles
(200 µl x 5 vial)
≈ 3.3 x 1010 copies/ml control lentiviral particles ready for transduction, 5 x 200 µl
LP-NEG-LV105-1000 Negative Control Lentifect™ Lentiviral Particles
(1 ml x 1 vial)
≈ 3.3 x 1010 copies/ml control lentiviral particles ready for transduction, 1 ml
LP-OCT4-LV105-0200 Oct4 Lentifect™ Lentiviral Particles
(200 µl x 1 vial)
≈ 4.5 x 108 TU/ml lentiviral particles ready for transduction, 200 µl
LP-OCT4-LV105-0205 Oct4 Lentifect™ Lentiviral Particles
(200 µl x 5 vials)
≈ 4.5 x 108 TU/ml lentiviral particles ready for transduction, 5 x 200 µl
LP-OCT4-LV105-1000 Oct4 Lentifect™ Lentiviral Particles
(1 ml x 1 vial)
≈ 4.5 x 108 TU/ml lentiviral particles ready for transduction, 1 x 1 ml
LP-RLUC-LV105-0200 Renilla Luciferase Lentifect™ Lentiviral Particles
(200 µl x 1 vial)
≈ 1 x 108 TU/ml control lentiviral particles ready for transduction, 200 µl
LP-RLUC-LV105-0205 Renilla Luciferase Lentifect™ Lentiviral Particles
(200 µl x 5 vials)
≈ 1 x 108 TU/ml control lentiviral particles ready for transduction, 5 x 200 µl
LP-RLUC-LV105-1000 Renilla Luciferase Lentifect™ Lentiviral Particles
(1 ml x 1 vial)
≈ 1 x 108 TU/ml control lentiviral particles ready for transduction, 1 x 1 ml
LP-SOX2-LV105-0200 Sox2 Lentifect™ Lentiviral Particles
(200 µl x 1 vial)
≈ 3.4 x 107 TU/ml lentiviral particles ready for transduction, 200 µl
LP-SOX2-LV105-0205 Sox2 Lentifect™ Lentiviral Particles
(200 µl x 5 vials)
≈ 3.4 x 107 TU/ml lentiviral particles ready for transduction, 5 x 200 µl
LP-SOX2-LV105-1000 Sox2 Lentifect™ Lentiviral Particles
(1 ml x 1 vial)
≈ 3.4 x 107 TU/ml lentiviral particles ready for transduction, 1 x 1 ml

*Titer determined by quantitative PCR on crude lentiviral supernatant.


Related products for lentiviral-based research—comprehensive solutions for infection of primary,
stem or non–dividing cells

Product Overview

 

Expressway to Discovery

Lenti-Pac™ HIV Expression
Packaging Kit
HIV-based lentiviral packaging plasmids with eGFP control clone and EndoFectin Lenti Transfection Reagent Delivers optimized production of recombinant lentivirus (HIV-based vectors)
Lenti-Pac™ FIV Expression
Packaging Kit
FIV-based lentiviral packaging plasmids with eGFP control clone and EndoFectin Lenti Transfection Reagent Delivers optimized production of recombinant lentivirus (FIV-based vectors)
GeneCopoeia293a Lentiviral Packaging Cell Line 1.5 x 106 cells Low passage and authenticated
GeneCopoeia GCI-L3 Chemically Competent E. coli Cells Ideally suited cells for transformation of lentiviral ORF cDNA clones High transformation efficiency with extremely low rates of recombination
OmicsLink™ Lentiviral ORF Expression Clones 25,000 human
15,000 mouse
CMV promoter-driven lentiviral expression vectors
Ready-to-transfect lentiviral
ORF cDNA clones for generation of lentiviral particles
OmicsLink™ Lentiviral Vector-Based shRNA Clones HIV- and FIV-based lentiviral vectors
with eGFP or mCherry reporter genes;
genome-wide coverage of
human, mouse and rat genes
Knockdown target genes confidently with minimal off-target effects
miExpress™ Precursor miRNA Expression Clones 750 human
450 mouse
270 rat
FIV-based lentiviral vectors with eGFP reporter gene
Study the regulatory and functional effect of miRNAs on corresponding genes and proteins
Endofectin™ Lenti Transfection Reagents Optimized for use with GeneCopoeia HIV-or FIV-Based
Lentiviral Expression Systems
Transfect efficiently and with low toxicity for reliable and reproducible results

Download Lentiviral Production Guidelines for information on ordering custom-made lentivirus.

Download Lenti-Pac Expression Packaging Kit product profile

Download Lentifect Crude Lentiviral Particles Data Sheets

Download Lentifect Purified Lentiviral Particles Data Sheets


   Copyright© 2001-2010 GeneCopoeia, Inc. All Rights Reserved. Contact us | License | Privacy